Member News

Flen Health Advisory Board Roundtable Discussion

Flen Health’s leadership team will be hosting an Advisory Board Roundtable in Boston on the 13th of July, from 5:00 pm to 9:00 pm at The Westin Copley Place. This roundtable coincides with the Advanced Wound Care Summit, which will also take place in Boston during the same week.

The discussion will focus on the nonclinical, clinical, regulatory, and reimbursement aspects of bringing Flaminal® through a drug or biological development pathway to the United States.

The panel will feature high-level experts from various fields. Amongst those confirmed are chief medical officers, executive directors, Alliance of Wound Care stakeholders, basic researchers in product development, dermatologists, vascular surgeons, clinical principal investigators, and regulatory and reimbursement experts.

Compliments of Flen Health – a premium member of the EACCNY.

About Flen Health
Flen Health is an international family-owned company located in Luxembourg, Belgium, the Netherlands, Germany, the United Kingdom, Ireland, the United States, and the United Arab Emirates. Our company’s success is based on the dedication of our people and our safe and easy-to-use product portfolio, which combines innovation with significant progress in skin and wound care and is inspired by our motto ‘live the life you love.’
We at Flen Health believe investing in innovative healing solutions helps to build a more secure life for all of us. We want to improve the quality of life of people suffering from wounds and skin diseases responsibly, by providing added value for patients, patients’ caregivers, healthcare professionals, health authorities, and the environment. Based on patented technologies, Flen Health develops and commercializes effective skin and wound healing solutions.
In recent years, Flen Health was labelled as an EU innovative company and has secured millions of non-dilutive funding for R&D activities, both within its innovation centres, as well as in collaboration with academic and institutional partners. Our products are distributed in more than 27 countries worldwide. Our current product portfolio includes: Flamigel®, Flaminal® Hydro, Flaminal® Forte, Flamirins®, extracalm®, Flamigel® RT, and Flamigel® Repair + Protect Handgel.
For more information, please visit our website at www.flenhealth.com, or contact us directly via email at info@flenhealth.com.